Real-world use of key performance indicators for point-of-Care Testing network accredited by ISO 22870

por Oliver, Paloma, Fernandez-Calle, Pilar, Mora, Roberto, Diaz-Garzon, Jorge, Prieto, Daniel, Manzano, Marta, Dominguez, Inmaculada, Buño, Antonio
Publicado 2020

Biocompatible DNA/5-Fluorouracil-Gemini Surfactant-Functionalized Gold Nanoparticles as Promising Vectors in Lung Cancer Therapy

por Giráldez-Pérez, Rosa M., Grueso, Elia, Domínguez, Inmaculada, Pastor, Nuria, Kuliszewska, Edyta, Prado-Gotor, Rafael, Requena-Domenech, Francisco
Publicado 2021

5-Aza-2′-deoxycytidine causes replication lesions that require Fanconi anemia-dependent homologous recombination for repair

por Orta, Manuel Luís, Calderón-Montaño, José Manuel, Domínguez, Inmaculada, Pastor, Nuria, Burgos-Morón, Estefanía, López-Lázaro, Miguel, Cortés, Felipe, Mateos, Santiago, Helleday, Thomas
Publicado 2013

The PARP inhibitor Olaparib disrupts base excision repair of 5-aza-2′-deoxycytidine lesions

por Orta, Manuel Luis, Höglund, Andreas, Calderón-Montaño, José Manuel, Domínguez, Inmaculada, Burgos-Morón, Estefanía, Visnes, Torkild, Pastor, Nuria, Ström, Cecilia, López-lázaro, Miguel, Helleday, Thomas
Publicado 2014

The Cockayne syndrome protein B is involved in the repair of 5-AZA-2′-deoxycytidine-induced DNA lesions

por Burgos-Morón, Estefanía, Calderón-Montaño, José Manuel, Pastor, Nuria, Höglund, Andreas, Ruiz-Castizo, Ángel, Domínguez, Inmaculada, López-Lázaro, Miguel, Hajji, Nabil, Helleday, Thomas, Mateos, Santiago, Orta, Manuel Luis
Publicado 2018